Abstract
In situ changes in the repertoire of integrins and proteolytic enzymes have been demonstrated during melanoma metastasis. To investigate whether established human melanoma cell lines, injected into nude mice, could undergo phenotypic changes similar to those observed in in situ lesions, we studied 3 melanoma cell lines of distinct metastatic origin, adherent HT-144 and SK-MEL-2 cells, and non-adherent SK-MEL-1 cells for integrin expression, proteolytic enzyme repertoire and invasive potential after in vitro culture. Heterogeneity in integrin expression, such as elevated levels in alpha(v)beta3 in SK-MEL-1 and SK-MEL-2 cells and low expression in HT-144 cells, correlated with their in vitro invasiveness, since only the adherent HT-144 and SK-MEL-2 cells were able to invade Matrigel, and in addition, secreted a 72-kDa gelatinase. In contrast, no similar correlation could be established in nude mice, as all 3 cell lines, including the non-adherent SK-MEL-1 cells, were tumorigenic when injected s.c., while only HT-144 consistently produced experimental lung metastasis. Immunochemical analysis of the integrin profile in s.c. xenografts revealed over-expression of alpha(v), beta1 and beta3 integrins exclusively in HT-144 cells, as we...Continue Reading
References
Mar 1, 1992·Clinical & Experimental Metastasis·K R GehlsenP Sriramarao
Jun 1, 1992·Trends in Biotechnology·A J DochertyG Murphy
Mar 1, 1992·Proceedings of the National Academy of Sciences of the United States of America·R E SeftorM J Hendrix
Jun 1, 1992·The Journal of Clinical Investigation·B Felding-HabermannD A Cheresh
Apr 3, 1992·Cell·R O Hynes
Mar 9, 1990·Cell·F G Giancotti, E Ruoslahti
Jan 27, 1989·Cell·L C Plantefaber, R O Hynes
Oct 1, 1989·American Journal of Clinical Pathology·B C McGregorR A Warnke
Nov 21, 1986·Cell·P MignattiD B Rifkin
Jul 25, 1986·Science·M J HumphriesK M Yamada
Mar 1, 1994·Histopathology·E H DanenD J Ruiter
Mar 3, 1995·International Journal of Cancer. Journal International Du Cancer·K JacobR Buettner
May 4, 1995·International Journal of Cancer. Journal International Du Cancer·S S VeigaR R Brentani
May 1, 1995·The Journal of Cell Biology·P HuhtalaC H Damsky
May 1, 1995·The Journal of Clinical Investigation·J NipP Brodt
May 16, 1995·International Journal of Cancer. Journal International Du Cancer·E H DanenG N Van Muijen
Jan 3, 1995·Proceedings of the National Academy of Sciences of the United States of America·B M MuellerW E Laug
Mar 1, 1994·European Journal of Biochemistry·H BoukercheJ L McGregor
May 6, 1994·Cell·F QianI L Weissman
Oct 1, 1993·Current Opinion in Cell Biology·R L Juliano, J A Varner
Citations
Aug 17, 2006·Journal of Virology·Annie C Y ChangStanley N Cohen
Apr 23, 2009·Molecular Cancer Therapeutics·David M SuYan A Su
Dec 18, 2007·Seminars in Oncology·A Neil CrowsonMartin C Mihm
Nov 12, 1998·The American Journal of Pathology·M Y HsuM Herlyn
May 20, 1999·Human Pathology·P A Van BelleD E Elder
Jul 20, 1999·Dermatologic Clinics·J A Reed, A P Albino
Mar 17, 1999·Japanese Journal of Cancer Research : Gann·M AsaiM Takahashi
Jun 29, 2000·Oncogene·B JanjiN Kieffer
Jul 27, 2001·Melanoma Research·A LityńskaD Gil
Jul 27, 2001·Melanoma Research·J K BakerK Sisley
May 9, 2002·The Journal of Biological Chemistry·Pekka Koistinen, Jyrki Heino
Sep 2, 1999·International Journal of Cancer. Journal International Du Cancer·B JanjiN Kieffer
Oct 20, 1999·Gynecologic Oncology·N ChattopadhyayA Chatterjee
Aug 3, 1999·Matrix Biology : Journal of the International Society for Matrix Biology·P KoistinenJ Heino
Jun 30, 2001·Cancer Letters·H M ReidH McGlynn
Mar 15, 2002·Seminars in Oncology·Roy S HerbstS Gail Eckhardt
Mar 24, 2004·Critical Reviews in Oncology/hematology·Sylvie PascoJean Claude Monboisse